Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GRAM domain containing 4 pseudogene 3 (GRAMD4P3) is a processed pseudogene, an inactive genomic DNA segment similar in sequence to the GRAM domain containing 4 gene but lacking the ability to encode a functional protein due to disabling mutations[1][3][5]. Pseudogenes like GRAMD4P3 can sometimes be transcribed and possibly participate in gene regulation (for example by acting as decoys for microRNAs or as competitors for RNA-binding proteins), but such functions have not been demonstrated for GRAMD4P3 specifically[6][7]. GRAMD4P3 is cataloged in major databases (HGNC:49138, NCBI Gene ID: 100631248, Ensembl: ENSG00000278301) as a non-protein coding processed pseudogene[1][3][5]. It is not known to be associated with any protein product, clinical disorder, or therapeutic intervention. Key context: - Pseudogenes are sometimes mistaken for active genes due to sequence similarity, but are typically non-functional and not considered therapeutic targets or biomarkers[2][6]. - Misamplification of pseudogenes can interfere with molecular assays, but this is a general concern and not specific to GRAMD4P3[2]. - While some pseudogenes participate in RNA-based regulatory functions or act as disease modifiers, no such role has been described for GRAMD4P3[6][7]. There are no drugs, mechanism of action, safety concerns, or biomarker evidence associated with this pseudogene, and it is catalogued for reference and annotation purposes only[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GRAM domain containing 4 pseudogene 3 (GRAMD4P3).